Literature DB >> 21738821

Quantitative analysis of p53 expression in human normal and cancer tissue microarray with global normalization method.

Halliday A Idikio1.   

Abstract

Tissue microarray based immunohistochemical staining and proteomics are important tools to create and validate clinically relevant cancer biomarkers. Immunohistochemical stains using formalin-fixed tissue microarray sections for protein expression are scored manually and semi-quantitatively. Digital image analysis methods remove some of the drawbacks of manual scoring but may need other methods such as normalization to provide across the board utility. In the present study, quantitative proteomics-based global normalization method was used to evaluate its utility in the analysis of p53 protein expression in mixed human normal and cancer tissue microarray. Global normalization used the mean or median of β-actin to calculate ratios of individual core stain intensities, then log transformed the ratios, calculate a mean or median and subtracted the value from the log of ratios. In the absence of global normalization of p53 protein expression, 44% (42 of 95) of tissue cores were positive using the median of intensity values and 40% (38 of 95) using the mean of intensities as cut-off points. With global normalization, p53 positive cores changed to 20% (19 of 95) when using median of intensities and 15.8%(15 of 95) when the mean of intensities were used. In conclusion, the global normalization method helped to define positive p53 staining in the tissue microarray set used. The method used helped to define clear cut-off points and confirmed all negatively stained tissue cores. Such normalization methods should help to better define clinically useful biomarkers.

Entities:  

Keywords:  Global normalization; cancer biomarkers; immunohistochemistry; p53protein

Mesh:

Substances:

Year:  2011        PMID: 21738821      PMCID: PMC3127071     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  59 in total

Review 1.  From signatures to models: understanding cancer using microarrays.

Authors:  Eran Segal; Nir Friedman; Naftali Kaminski; Aviv Regev; Daphne Koller
Journal:  Nat Genet       Date:  2005-06       Impact factor: 38.330

2.  Spindle checkpoint protein hMad2 and histone H3 phosphoserine 10 mitosis marker in pediatric solid tumors.

Authors:  Halliday A Idikio
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

3.  Galectin-3 expression in human breast carcinoma: correlation with cancer histologic grade.

Authors:  H Idikio
Journal:  Int J Oncol       Date:  1998-06       Impact factor: 5.650

Review 4.  TP53 mutations in human cancers: origins, consequences, and clinical use.

Authors:  Magali Olivier; Monica Hollstein; Pierre Hainaut
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-01       Impact factor: 10.005

5.  Regulation of autophagy by cytoplasmic p53.

Authors:  Ezgi Tasdemir; M Chiara Maiuri; Lorenzo Galluzzi; Ilio Vitale; Mojgan Djavaheri-Mergny; Marcello D'Amelio; Alfredo Criollo; Eugenia Morselli; Changlian Zhu; Francis Harper; Ulf Nannmark; Chrysanthi Samara; Paolo Pinton; José Miguel Vicencio; Rosa Carnuccio; Ute M Moll; Frank Madeo; Patrizia Paterlini-Brechot; Rosario Rizzuto; Gyorgy Szabadkai; Gérard Pierron; Klas Blomgren; Nektarios Tavernarakis; Patrice Codogno; Francesco Cecconi; Guido Kroemer
Journal:  Nat Cell Biol       Date:  2008-05-04       Impact factor: 28.824

6.  Supervised normalization of microarrays.

Authors:  Brigham H Mecham; Peter S Nelson; John D Storey
Journal:  Bioinformatics       Date:  2010-03-31       Impact factor: 6.937

7.  Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

Authors:  Soledad R Alonso; Pablo Ortiz; Marina Pollán; Beatriz Pérez-Gómez; Lydia Sánchez; Ma Jesús Acuña; Raquel Pajares; Francisco J Martínez-Tello; Carlos M Hortelano; Miguel A Piris; José L Rodríguez-Peralto
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

Review 8.  From bytes to bedside: data integration and computational biology for translational cancer research.

Authors:  Jomol P Mathew; Barry S Taylor; Gary D Bader; Saiju Pyarajan; Marco Antoniotti; Arul M Chinnaiyan; Chris Sander; Steven J Burakoff; Bud Mishra
Journal:  PLoS Comput Biol       Date:  2007-02-23       Impact factor: 4.475

9.  Processing methods for differential analysis of LC/MS profile data.

Authors:  Mikko Katajamaa; Matej Oresic
Journal:  BMC Bioinformatics       Date:  2005-07-18       Impact factor: 3.169

10.  Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients.

Authors:  Andrea Sassen; Justine Rochon; Peter Wild; Arndt Hartmann; Ferdinand Hofstaedter; Stephan Schwarz; Gero Brockhoff
Journal:  Breast Cancer Res       Date:  2008-01-08       Impact factor: 6.466

View more
  3 in total

1.  LOX and ACSL5 as potential relapse markers for pancreatic cancer patients.

Authors:  Weidong Ma; Ting Li; Si Wu; Jian Li; Xiuchao Wang; Hui Li
Journal:  Cancer Biol Ther       Date:  2019-02-03       Impact factor: 4.742

2.  Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer.

Authors:  Lei Jia; Fan Yan; Wenfeng Cao; Zhengming Chen; Hong Zheng; Haixin Li; Yi Pan; Navneet Narula; Xiubao Ren; Hui Li; Pengbo Zhou
Journal:  J Biol Chem       Date:  2016-12-14       Impact factor: 5.157

3.  TMAinspiration: Decode Interdependencies in Multifactorial Tissue Microarray Data.

Authors:  Florian Boecker; Horst Buerger; Nikhil V Mallela; Eberhard Korsching
Journal:  Cancer Inform       Date:  2016-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.